img

Global Glycopyrronium Bromide API Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Glycopyrronium Bromide API Market Research Report 2024

Glycopyrronium bromide is an active pharmaceutical ingredient (API) used in the formulation of various pharmaceutical products, particularly in the field of respiratory medicine. It is a synthetic quaternary ammonium compound that belongs to the class of anticholinergic agents.
According to Mr Accuracy reports’s new survey, global Glycopyrronium Bromide API market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Glycopyrronium Bromide API market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glycopyrronium Bromide API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Neuraxpharm
Seqens
Cerbios Pharma
Harman Finochem
Tai Heng Industry
Amsa Spa
Boehringer Ingelheim
Hovione
Sifavitor srl
Hainan Poly Pharm
Suven Life Sciences
Resonance Laboratories
Hikma Pharmaceuticals
Endo International
Siegfried
Dipharma
Aurobindo Pharma
Synergene Active Ingredients
Aragen Life Sciences
Tooba Pharmaceuticals
Cipla
Guangzhou Tosun Pharmaceutical
Olon
Khandelwal Laboratories
Stason Pharmaceuticals
Segment by Type
USP
EP

Segment by Application


Hyperhidrosis
Severe Drooling
COPD

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Glycopyrronium Bromide API report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Glycopyrronium Bromide API Market Overview
1.1 Product Overview and Scope of Glycopyrronium Bromide API
1.2 Glycopyrronium Bromide API Segment by Type
1.2.1 Global Glycopyrronium Bromide API Market Value Comparison by Type (2024-2034)
1.2.2 USP
1.2.3 EP
1.3 Glycopyrronium Bromide API Segment by Application
1.3.1 Global Glycopyrronium Bromide API Market Value by Application: (2024-2034)
1.3.2 Hyperhidrosis
1.3.3 Severe Drooling
1.3.4 COPD
1.4 Global Glycopyrronium Bromide API Market Size Estimates and Forecasts
1.4.1 Global Glycopyrronium Bromide API Revenue 2018-2029
1.4.2 Global Glycopyrronium Bromide API Sales 2018-2029
1.4.3 Global Glycopyrronium Bromide API Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Glycopyrronium Bromide API Market Competition by Manufacturers
2.1 Global Glycopyrronium Bromide API Sales Market Share by Manufacturers (2018-2024)
2.2 Global Glycopyrronium Bromide API Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Glycopyrronium Bromide API Average Price by Manufacturers (2018-2024)
2.4 Global Glycopyrronium Bromide API Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Glycopyrronium Bromide API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glycopyrronium Bromide API, Product Type & Application
2.7 Glycopyrronium Bromide API Market Competitive Situation and Trends
2.7.1 Glycopyrronium Bromide API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glycopyrronium Bromide API Players Market Share by Revenue
2.7.3 Global Glycopyrronium Bromide API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glycopyrronium Bromide API Retrospective Market Scenario by Region
3.1 Global Glycopyrronium Bromide API Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Glycopyrronium Bromide API Global Glycopyrronium Bromide API Sales by Region: 2018-2029
3.2.1 Global Glycopyrronium Bromide API Sales by Region: 2018-2024
3.2.2 Global Glycopyrronium Bromide API Sales by Region: 2024-2029
3.3 Global Glycopyrronium Bromide API Global Glycopyrronium Bromide API Revenue by Region: 2018-2029
3.3.1 Global Glycopyrronium Bromide API Revenue by Region: 2018-2024
3.3.2 Global Glycopyrronium Bromide API Revenue by Region: 2024-2029
3.4 North America Glycopyrronium Bromide API Market Facts & Figures by Country
3.4.1 North America Glycopyrronium Bromide API Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Glycopyrronium Bromide API Sales by Country (2018-2029)
3.4.3 North America Glycopyrronium Bromide API Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Glycopyrronium Bromide API Market Facts & Figures by Country
3.5.1 Europe Glycopyrronium Bromide API Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Glycopyrronium Bromide API Sales by Country (2018-2029)
3.5.3 Europe Glycopyrronium Bromide API Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glycopyrronium Bromide API Market Facts & Figures by Country
3.6.1 Asia Pacific Glycopyrronium Bromide API Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Glycopyrronium Bromide API Sales by Country (2018-2029)
3.6.3 Asia Pacific Glycopyrronium Bromide API Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Glycopyrronium Bromide API Market Facts & Figures by Country
3.7.1 Latin America Glycopyrronium Bromide API Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Glycopyrronium Bromide API Sales by Country (2018-2029)
3.7.3 Latin America Glycopyrronium Bromide API Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glycopyrronium Bromide API Market Facts & Figures by Country
3.8.1 Middle East and Africa Glycopyrronium Bromide API Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Glycopyrronium Bromide API Sales by Country (2018-2029)
3.8.3 Middle East and Africa Glycopyrronium Bromide API Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glycopyrronium Bromide API Sales by Type (2018-2029)
4.1.1 Global Glycopyrronium Bromide API Sales by Type (2018-2024)
4.1.2 Global Glycopyrronium Bromide API Sales by Type (2024-2029)
4.1.3 Global Glycopyrronium Bromide API Sales Market Share by Type (2018-2029)
4.2 Global Glycopyrronium Bromide API Revenue by Type (2018-2029)
4.2.1 Global Glycopyrronium Bromide API Revenue by Type (2018-2024)
4.2.2 Global Glycopyrronium Bromide API Revenue by Type (2024-2029)
4.2.3 Global Glycopyrronium Bromide API Revenue Market Share by Type (2018-2029)
4.3 Global Glycopyrronium Bromide API Price by Type (2018-2029)
5 Segment by Application
5.1 Global Glycopyrronium Bromide API Sales by Application (2018-2029)
5.1.1 Global Glycopyrronium Bromide API Sales by Application (2018-2024)
5.1.2 Global Glycopyrronium Bromide API Sales by Application (2024-2029)
5.1.3 Global Glycopyrronium Bromide API Sales Market Share by Application (2018-2029)
5.2 Global Glycopyrronium Bromide API Revenue by Application (2018-2029)
5.2.1 Global Glycopyrronium Bromide API Revenue by Application (2018-2024)
5.2.2 Global Glycopyrronium Bromide API Revenue by Application (2024-2029)
5.2.3 Global Glycopyrronium Bromide API Revenue Market Share by Application (2018-2029)
5.3 Global Glycopyrronium Bromide API Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Neuraxpharm
6.1.1 Neuraxpharm Corporation Information
6.1.2 Neuraxpharm Description and Business Overview
6.1.3 Neuraxpharm Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Neuraxpharm Glycopyrronium Bromide API Product Portfolio
6.1.5 Neuraxpharm Recent Developments/Updates
6.2 Seqens
6.2.1 Seqens Corporation Information
6.2.2 Seqens Description and Business Overview
6.2.3 Seqens Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Seqens Glycopyrronium Bromide API Product Portfolio
6.2.5 Seqens Recent Developments/Updates
6.3 Cerbios Pharma
6.3.1 Cerbios Pharma Corporation Information
6.3.2 Cerbios Pharma Description and Business Overview
6.3.3 Cerbios Pharma Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Cerbios Pharma Glycopyrronium Bromide API Product Portfolio
6.3.5 Cerbios Pharma Recent Developments/Updates
6.4 Harman Finochem
6.4.1 Harman Finochem Corporation Information
6.4.2 Harman Finochem Description and Business Overview
6.4.3 Harman Finochem Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Harman Finochem Glycopyrronium Bromide API Product Portfolio
6.4.5 Harman Finochem Recent Developments/Updates
6.5 Tai Heng Industry
6.5.1 Tai Heng Industry Corporation Information
6.5.2 Tai Heng Industry Description and Business Overview
6.5.3 Tai Heng Industry Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Tai Heng Industry Glycopyrronium Bromide API Product Portfolio
6.5.5 Tai Heng Industry Recent Developments/Updates
6.6 Amsa Spa
6.6.1 Amsa Spa Corporation Information
6.6.2 Amsa Spa Description and Business Overview
6.6.3 Amsa Spa Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Amsa Spa Glycopyrronium Bromide API Product Portfolio
6.6.5 Amsa Spa Recent Developments/Updates
6.7 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Boehringer Ingelheim Glycopyrronium Bromide API Product Portfolio
6.7.5 Boehringer Ingelheim Recent Developments/Updates
6.8 Hovione
6.8.1 Hovione Corporation Information
6.8.2 Hovione Description and Business Overview
6.8.3 Hovione Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Hovione Glycopyrronium Bromide API Product Portfolio
6.8.5 Hovione Recent Developments/Updates
6.9 Sifavitor srl
6.9.1 Sifavitor srl Corporation Information
6.9.2 Sifavitor srl Description and Business Overview
6.9.3 Sifavitor srl Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Sifavitor srl Glycopyrronium Bromide API Product Portfolio
6.9.5 Sifavitor srl Recent Developments/Updates
6.10 Hainan Poly Pharm
6.10.1 Hainan Poly Pharm Corporation Information
6.10.2 Hainan Poly Pharm Description and Business Overview
6.10.3 Hainan Poly Pharm Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Hainan Poly Pharm Glycopyrronium Bromide API Product Portfolio
6.10.5 Hainan Poly Pharm Recent Developments/Updates
6.11 Suven Life Sciences
6.11.1 Suven Life Sciences Corporation Information
6.11.2 Suven Life Sciences Glycopyrronium Bromide API Description and Business Overview
6.11.3 Suven Life Sciences Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Suven Life Sciences Glycopyrronium Bromide API Product Portfolio
6.11.5 Suven Life Sciences Recent Developments/Updates
6.12 Resonance Laboratories
6.12.1 Resonance Laboratories Corporation Information
6.12.2 Resonance Laboratories Glycopyrronium Bromide API Description and Business Overview
6.12.3 Resonance Laboratories Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Resonance Laboratories Glycopyrronium Bromide API Product Portfolio
6.12.5 Resonance Laboratories Recent Developments/Updates
6.13 Hikma Pharmaceuticals
6.13.1 Hikma Pharmaceuticals Corporation Information
6.13.2 Hikma Pharmaceuticals Glycopyrronium Bromide API Description and Business Overview
6.13.3 Hikma Pharmaceuticals Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Hikma Pharmaceuticals Glycopyrronium Bromide API Product Portfolio
6.13.5 Hikma Pharmaceuticals Recent Developments/Updates
6.14 Endo International
6.14.1 Endo International Corporation Information
6.14.2 Endo International Glycopyrronium Bromide API Description and Business Overview
6.14.3 Endo International Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Endo International Glycopyrronium Bromide API Product Portfolio
6.14.5 Endo International Recent Developments/Updates
6.15 Siegfried
6.15.1 Siegfried Corporation Information
6.15.2 Siegfried Glycopyrronium Bromide API Description and Business Overview
6.15.3 Siegfried Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Siegfried Glycopyrronium Bromide API Product Portfolio
6.15.5 Siegfried Recent Developments/Updates
6.16 Dipharma
6.16.1 Dipharma Corporation Information
6.16.2 Dipharma Glycopyrronium Bromide API Description and Business Overview
6.16.3 Dipharma Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Dipharma Glycopyrronium Bromide API Product Portfolio
6.16.5 Dipharma Recent Developments/Updates
6.17 Aurobindo Pharma
6.17.1 Aurobindo Pharma Corporation Information
6.17.2 Aurobindo Pharma Glycopyrronium Bromide API Description and Business Overview
6.17.3 Aurobindo Pharma Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Aurobindo Pharma Glycopyrronium Bromide API Product Portfolio
6.17.5 Aurobindo Pharma Recent Developments/Updates
6.18 Synergene Active Ingredients
6.18.1 Synergene Active Ingredients Corporation Information
6.18.2 Synergene Active Ingredients Glycopyrronium Bromide API Description and Business Overview
6.18.3 Synergene Active Ingredients Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Synergene Active Ingredients Glycopyrronium Bromide API Product Portfolio
6.18.5 Synergene Active Ingredients Recent Developments/Updates
6.19 Aragen Life Sciences
6.19.1 Aragen Life Sciences Corporation Information
6.19.2 Aragen Life Sciences Glycopyrronium Bromide API Description and Business Overview
6.19.3 Aragen Life Sciences Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Aragen Life Sciences Glycopyrronium Bromide API Product Portfolio
6.19.5 Aragen Life Sciences Recent Developments/Updates
6.20 Tooba Pharmaceuticals
6.20.1 Tooba Pharmaceuticals Corporation Information
6.20.2 Tooba Pharmaceuticals Glycopyrronium Bromide API Description and Business Overview
6.20.3 Tooba Pharmaceuticals Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Tooba Pharmaceuticals Glycopyrronium Bromide API Product Portfolio
6.20.5 Tooba Pharmaceuticals Recent Developments/Updates
6.21 Cipla
6.21.1 Cipla Corporation Information
6.21.2 Cipla Glycopyrronium Bromide API Description and Business Overview
6.21.3 Cipla Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Cipla Glycopyrronium Bromide API Product Portfolio
6.21.5 Cipla Recent Developments/Updates
6.22 Guangzhou Tosun Pharmaceutical
6.22.1 Guangzhou Tosun Pharmaceutical Corporation Information
6.22.2 Guangzhou Tosun Pharmaceutical Glycopyrronium Bromide API Description and Business Overview
6.22.3 Guangzhou Tosun Pharmaceutical Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Guangzhou Tosun Pharmaceutical Glycopyrronium Bromide API Product Portfolio
6.22.5 Guangzhou Tosun Pharmaceutical Recent Developments/Updates
6.23 Olon
6.23.1 Olon Corporation Information
6.23.2 Olon Glycopyrronium Bromide API Description and Business Overview
6.23.3 Olon Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.23.4 Olon Glycopyrronium Bromide API Product Portfolio
6.23.5 Olon Recent Developments/Updates
6.24 Khandelwal Laboratories
6.24.1 Khandelwal Laboratories Corporation Information
6.24.2 Khandelwal Laboratories Glycopyrronium Bromide API Description and Business Overview
6.24.3 Khandelwal Laboratories Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.24.4 Khandelwal Laboratories Glycopyrronium Bromide API Product Portfolio
6.24.5 Khandelwal Laboratories Recent Developments/Updates
6.25 Stason Pharmaceuticals
6.25.1 Stason Pharmaceuticals Corporation Information
6.25.2 Stason Pharmaceuticals Glycopyrronium Bromide API Description and Business Overview
6.25.3 Stason Pharmaceuticals Glycopyrronium Bromide API Sales, Revenue and Gross Margin (2018-2024)
6.25.4 Stason Pharmaceuticals Glycopyrronium Bromide API Product Portfolio
6.25.5 Stason Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glycopyrronium Bromide API Industry Chain Analysis
7.2 Glycopyrronium Bromide API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glycopyrronium Bromide API Production Mode & Process
7.4 Glycopyrronium Bromide API Sales and Marketing
7.4.1 Glycopyrronium Bromide API Sales Channels
7.4.2 Glycopyrronium Bromide API Distributors
7.5 Glycopyrronium Bromide API Customers
8 Glycopyrronium Bromide API Market Dynamics
8.1 Glycopyrronium Bromide API Industry Trends
8.2 Glycopyrronium Bromide API Market Drivers
8.3 Glycopyrronium Bromide API Market Challenges
8.4 Glycopyrronium Bromide API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Glycopyrronium Bromide API Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Glycopyrronium Bromide API Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Glycopyrronium Bromide API Market Competitive Situation by Manufacturers in 2022
Table 4. Global Glycopyrronium Bromide API Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Glycopyrronium Bromide API Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Glycopyrronium Bromide API Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Glycopyrronium Bromide API Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Glycopyrronium Bromide API Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Glycopyrronium Bromide API, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Glycopyrronium Bromide API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Glycopyrronium Bromide API, Product Type & Application
Table 12. Global Key Manufacturers of Glycopyrronium Bromide API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Glycopyrronium Bromide API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycopyrronium Bromide API as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Glycopyrronium Bromide API Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Glycopyrronium Bromide API Sales by Region (2018-2024) & (K Units)
Table 18. Global Glycopyrronium Bromide API Sales Market Share by Region (2018-2024)
Table 19. Global Glycopyrronium Bromide API Sales by Region (2024-2029) & (K Units)
Table 20. Global Glycopyrronium Bromide API Sales Market Share by Region (2024-2029)
Table 21. Global Glycopyrronium Bromide API Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Glycopyrronium Bromide API Revenue Market Share by Region (2018-2024)
Table 23. Global Glycopyrronium Bromide API Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Glycopyrronium Bromide API Revenue Market Share by Region (2024-2029)
Table 25. North America Glycopyrronium Bromide API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Glycopyrronium Bromide API Sales by Country (2018-2024) & (K Units)
Table 27. North America Glycopyrronium Bromide API Sales by Country (2024-2029) & (K Units)
Table 28. North America Glycopyrronium Bromide API Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Glycopyrronium Bromide API Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Glycopyrronium Bromide API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Glycopyrronium Bromide API Sales by Country (2018-2024) & (K Units)
Table 32. Europe Glycopyrronium Bromide API Sales by Country (2024-2029) & (K Units)
Table 33. Europe Glycopyrronium Bromide API Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Glycopyrronium Bromide API Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Glycopyrronium Bromide API Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Glycopyrronium Bromide API Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Glycopyrronium Bromide API Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Glycopyrronium Bromide API Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Glycopyrronium Bromide API Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Glycopyrronium Bromide API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Glycopyrronium Bromide API Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Glycopyrronium Bromide API Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Glycopyrronium Bromide API Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Glycopyrronium Bromide API Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Glycopyrronium Bromide API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Glycopyrronium Bromide API Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Glycopyrronium Bromide API Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Glycopyrronium Bromide API Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Glycopyrronium Bromide API Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Glycopyrronium Bromide API Sales (K Units) by Type (2018-2024)
Table 51. Global Glycopyrronium Bromide API Sales (K Units) by Type (2024-2029)
Table 52. Global Glycopyrronium Bromide API Sales Market Share by Type (2018-2024)
Table 53. Global Glycopyrronium Bromide API Sales Market Share by Type (2024-2029)
Table 54. Global Glycopyrronium Bromide API Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Glycopyrronium Bromide API Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Glycopyrronium Bromide API Revenue Market Share by Type (2018-2024)
Table 57. Global Glycopyrronium Bromide API Revenue Market Share by Type (2024-2029)
Table 58. Global Glycopyrronium Bromide API Price (US$/Unit) by Type (2018-2024)
Table 59. Global Glycopyrronium Bromide API Price (US$/Unit) by Type (2024-2029)
Table 60. Global Glycopyrronium Bromide API Sales (K Units) by Application (2018-2024)
Table 61. Global Glycopyrronium Bromide API Sales (K Units) by Application (2024-2029)
Table 62. Global Glycopyrronium Bromide API Sales Market Share by Application (2018-2024)
Table 63. Global Glycopyrronium Bromide API Sales Market Share by Application (2024-2029)
Table 64. Global Glycopyrronium Bromide API Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Glycopyrronium Bromide API Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Glycopyrronium Bromide API Revenue Market Share by Application (2018-2024)
Table 67. Global Glycopyrronium Bromide API Revenue Market Share by Application (2024-2029)
Table 68. Global Glycopyrronium Bromide API Price (US$/Unit) by Application (2018-2024)
Table 69. Global Glycopyrronium Bromide API Price (US$/Unit) by Application (2024-2029)
Table 70. Neuraxpharm Corporation Information
Table 71. Neuraxpharm Description and Business Overview
Table 72. Neuraxpharm Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Neuraxpharm Glycopyrronium Bromide API Product
Table 74. Neuraxpharm Recent Developments/Updates
Table 75. Seqens Corporation Information
Table 76. Seqens Description and Business Overview
Table 77. Seqens Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Seqens Glycopyrronium Bromide API Product
Table 79. Seqens Recent Developments/Updates
Table 80. Cerbios Pharma Corporation Information
Table 81. Cerbios Pharma Description and Business Overview
Table 82. Cerbios Pharma Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Cerbios Pharma Glycopyrronium Bromide API Product
Table 84. Cerbios Pharma Recent Developments/Updates
Table 85. Harman Finochem Corporation Information
Table 86. Harman Finochem Description and Business Overview
Table 87. Harman Finochem Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Harman Finochem Glycopyrronium Bromide API Product
Table 89. Harman Finochem Recent Developments/Updates
Table 90. Tai Heng Industry Corporation Information
Table 91. Tai Heng Industry Description and Business Overview
Table 92. Tai Heng Industry Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Tai Heng Industry Glycopyrronium Bromide API Product
Table 94. Tai Heng Industry Recent Developments/Updates
Table 95. Amsa Spa Corporation Information
Table 96. Amsa Spa Description and Business Overview
Table 97. Amsa Spa Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Amsa Spa Glycopyrronium Bromide API Product
Table 99. Amsa Spa Recent Developments/Updates
Table 100. Boehringer Ingelheim Corporation Information
Table 101. Boehringer Ingelheim Description and Business Overview
Table 102. Boehringer Ingelheim Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Boehringer Ingelheim Glycopyrronium Bromide API Product
Table 104. Boehringer Ingelheim Recent Developments/Updates
Table 105. Hovione Corporation Information
Table 106. Hovione Description and Business Overview
Table 107. Hovione Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Hovione Glycopyrronium Bromide API Product
Table 109. Hovione Recent Developments/Updates
Table 110. Sifavitor srl Corporation Information
Table 111. Sifavitor srl Description and Business Overview
Table 112. Sifavitor srl Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Sifavitor srl Glycopyrronium Bromide API Product
Table 114. Sifavitor srl Recent Developments/Updates
Table 115. Hainan Poly Pharm Corporation Information
Table 116. Hainan Poly Pharm Description and Business Overview
Table 117. Hainan Poly Pharm Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Hainan Poly Pharm Glycopyrronium Bromide API Product
Table 119. Hainan Poly Pharm Recent Developments/Updates
Table 120. Suven Life Sciences Corporation Information
Table 121. Suven Life Sciences Description and Business Overview
Table 122. Suven Life Sciences Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Suven Life Sciences Glycopyrronium Bromide API Product
Table 124. Suven Life Sciences Recent Developments/Updates
Table 125. Resonance Laboratories Corporation Information
Table 126. Resonance Laboratories Description and Business Overview
Table 127. Resonance Laboratories Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Resonance Laboratories Glycopyrronium Bromide API Product
Table 129. Resonance Laboratories Recent Developments/Updates
Table 130. Hikma Pharmaceuticals Corporation Information
Table 131. Hikma Pharmaceuticals Description and Business Overview
Table 132. Hikma Pharmaceuticals Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Hikma Pharmaceuticals Glycopyrronium Bromide API Product
Table 134. Hikma Pharmaceuticals Recent Developments/Updates
Table 135. Endo International Corporation Information
Table 136. Endo International Description and Business Overview
Table 137. Endo International Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Endo International Glycopyrronium Bromide API Product
Table 139. Endo International Recent Developments/Updates
Table 140. Siegfried Corporation Information
Table 141. Siegfried Description and Business Overview
Table 142. Siegfried Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Siegfried Glycopyrronium Bromide API Product
Table 144. Siegfried Recent Developments/Updates
Table 145. Dipharma Corporation Information
Table 146. Dipharma Description and Business Overview
Table 147. Dipharma Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Dipharma Glycopyrronium Bromide API Product
Table 149. Dipharma Recent Developments/Updates
Table 150. Aurobindo Pharma Corporation Information
Table 151. Aurobindo Pharma Description and Business Overview
Table 152. Aurobindo Pharma Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Aurobindo Pharma Glycopyrronium Bromide API Product
Table 154. Aurobindo Pharma Recent Developments/Updates
Table 155. Synergene Active Ingredients Corporation Information
Table 156. Synergene Active Ingredients Description and Business Overview
Table 157. Synergene Active Ingredients Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Synergene Active Ingredients Glycopyrronium Bromide API Product
Table 159. Synergene Active Ingredients Recent Developments/Updates
Table 160. Aragen Life Sciences Corporation Information
Table 161. Aragen Life Sciences Description and Business Overview
Table 162. Aragen Life Sciences Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Aragen Life Sciences Glycopyrronium Bromide API Product
Table 164. Aragen Life Sciences Recent Developments/Updates
Table 165. Tooba Pharmaceuticals Corporation Information
Table 166. Tooba Pharmaceuticals Description and Business Overview
Table 167. Tooba Pharmaceuticals Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Tooba Pharmaceuticals Glycopyrronium Bromide API Product
Table 169. Tooba Pharmaceuticals Recent Developments/Updates
Table 170. Cipla Corporation Information
Table 171. Cipla Description and Business Overview
Table 172. Cipla Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Cipla Glycopyrronium Bromide API Product
Table 174. Cipla Recent Developments/Updates
Table 175. Guangzhou Tosun Pharmaceutical Corporation Information
Table 176. Guangzhou Tosun Pharmaceutical Description and Business Overview
Table 177. Guangzhou Tosun Pharmaceutical Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Guangzhou Tosun Pharmaceutical Glycopyrronium Bromide API Product
Table 179. Guangzhou Tosun Pharmaceutical Recent Developments/Updates
Table 180. Olon Corporation Information
Table 181. Olon Description and Business Overview
Table 182. Olon Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Olon Glycopyrronium Bromide API Product
Table 184. Olon Recent Developments/Updates
Table 185. Khandelwal Laboratories Corporation Information
Table 186. Khandelwal Laboratories Description and Business Overview
Table 187. Khandelwal Laboratories Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 188. Khandelwal Laboratories Glycopyrronium Bromide API Product
Table 189. Khandelwal Laboratories Recent Developments/Updates
Table 190. Stason Pharmaceuticals Corporation Information
Table 191. Stason Pharmaceuticals Description and Business Overview
Table 192. Stason Pharmaceuticals Glycopyrronium Bromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 193. Stason Pharmaceuticals Glycopyrronium Bromide API Product
Table 194. Stason Pharmaceuticals Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Glycopyrronium Bromide API Distributors List
Table 198. Glycopyrronium Bromide API Customers List
Table 199. Glycopyrronium Bromide API Market Trends
Table 200. Glycopyrronium Bromide API Market Drivers
Table 201. Glycopyrronium Bromide API Market Challenges
Table 202. Glycopyrronium Bromide API Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Glycopyrronium Bromide API
Figure 2. Global Glycopyrronium Bromide API Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Glycopyrronium Bromide API Market Share by Type in 2022 & 2029
Figure 4. USP Product Picture
Figure 5. EP Product Picture
Figure 6. Global Glycopyrronium Bromide API Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Glycopyrronium Bromide API Market Share by Application in 2022 & 2029
Figure 8. Hyperhidrosis
Figure 9. Severe Drooling
Figure 10. COPD
Figure 11. Global Glycopyrronium Bromide API Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Glycopyrronium Bromide API Market Size (2018-2029) & (US$ Million)
Figure 13. Global Glycopyrronium Bromide API Sales (2018-2029) & (K Units)
Figure 14. Global Glycopyrronium Bromide API Average Price (US$/Unit) & (2018-2029)
Figure 15. Glycopyrronium Bromide API Report Years Considered
Figure 16. Glycopyrronium Bromide API Sales Share by Manufacturers in 2022
Figure 17. Global Glycopyrronium Bromide API Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Glycopyrronium Bromide API Players: Market Share by Revenue in 2022
Figure 19. Glycopyrronium Bromide API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Glycopyrronium Bromide API Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Glycopyrronium Bromide API Sales Market Share by Country (2018-2029)
Figure 22. North America Glycopyrronium Bromide API Revenue Market Share by Country (2018-2029)
Figure 23. United States Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Glycopyrronium Bromide API Sales Market Share by Country (2018-2029)
Figure 26. Europe Glycopyrronium Bromide API Revenue Market Share by Country (2018-2029)
Figure 27. Germany Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Glycopyrronium Bromide API Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Glycopyrronium Bromide API Revenue Market Share by Region (2018-2029)
Figure 34. China Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Glycopyrronium Bromide API Sales Market Share by Country (2018-2029)
Figure 42. Latin America Glycopyrronium Bromide API Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Glycopyrronium Bromide API Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Glycopyrronium Bromide API Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Glycopyrronium Bromide API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Glycopyrronium Bromide API by Type (2018-2029)
Figure 52. Global Revenue Market Share of Glycopyrronium Bromide API by Type (2018-2029)
Figure 53. Global Glycopyrronium Bromide API Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Glycopyrronium Bromide API by Application (2018-2029)
Figure 55. Global Revenue Market Share of Glycopyrronium Bromide API by Application (2018-2029)
Figure 56. Global Glycopyrronium Bromide API Price (US$/Unit) by Application (2018-2029)
Figure 57. Glycopyrronium Bromide API Value Chain
Figure 58. Glycopyrronium Bromide API Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed